| 1/2 | US=50 / Câncer Rugo HS, Lin AYJ. Targeted therapy for breast cancer: a focus on HER2/neu and antiangiogenic therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 497-509. ISBN 978-1-60327-086-1. TERAPIA-ALVO PARA CANCER DE MAMA; HER2/NEU E TERAPIA ANTIANGIOGENICA; CANCER DE MAMA METASTATICO; HER2/NEU; TRASTUZUMAB; LAPATINIB; BEVACIZUMAB; SUNITINIB; ANTIANGIOGENICO; TERAPIA-ALVO |
| 2/2 | US=47 / Clín/Medica Traina A, Agostara B, Marasa L, Calabro M, Zarcone M, Carruba G. HER2/neu expression. in relation to clinicopathologic features of breast câncer patients. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 159-67. ISBN 978-1-57331-699-5. |